🔴
Haematospermia — Primary Care Assessment Structured 9-step pathway for blood in semen · UK GP / RCGP SCA preparation
Progress 0 / 9
The full reasoning pathway — in younger men haematospermia is benign and self-limiting; in older men, or when persistent, it needs assessment for prostate and urological pathology. Treat the cause and safety-net.StartDecisionInvestigateActionReferStop / Admit
PresentationBlood in semen
Age, duration, recurrence, urinary symptoms, haematuria, bleeding tendency. Examine genitalia + DRE; urinalysis; BP.
Step 1 · Safety — older / persistent / red flagsOlder / persistent / red flags?
Age >40 with persistent or recurrent haematospermia · associated haematuria · abnormal prostate / raised PSA · systemic features.
YES
Stop · Escalate2WW / urology
Suspicious prostate or PSA → 2WW. Persistent/older → urology assessment.
NO
AssessBy pattern
History + examination localise the cause.
Step 3 · common causes
Young, single episode
Benign
Idiopathic, post-procedure, infection; reassure — usually self-limiting.
Infective / inflammatory
Treat
Prostatitis, epididymitis, STI; treat + screen.
Urological
Investigate
Prostate pathology, BPH, calculi; PSA, USS as indicated.
Step 6 · ReferEscalation
2WW abnormal prostate / raised PSA. Urology persistent or recurrent haematospermia (especially >40), or with haematuria.
Step 8 · reassurance & modifiable factors
Step 8 · Reassurance & modifiable factorsMost younger men just need explanation
Reassure younger men with a single/short episode and normal exam that it is benign and self-limiting. Treat infection/STI (and offer screening + partner notification); manage prostatitis. Review anticoagulants/antiplatelets and control hypertension (a contributor). Note recent prostate biopsy/instrumentation as a cause.
Step 9 · review & safety-net
Step 9 · Review & safety-netWhen to escalate
Return if it persists or recurs beyond a few episodes, or if associated with visible haematuria, weight loss, bone pain, or an abnormal prostate → urology + PSA. Low threshold for assessment in men aged >40. Safety-net that benign reassurance applies only to the young man with a normal examination.
⚠️ A single episode in a young man is benign and needs only reassurance — but persistent or recurrent haematospermia in older men warrants a prostate assessment and PSA.
1
Safety

Red Flags — Exclude life-threatening causes first

Haematospermia is usually benign and self-limiting in men under 40. In older men or with concurrent symptoms, exclude malignancy and serious infection urgently.

Age ≥40 + recurrent Persistent haematospermia ≥3 episodes or >1 month → 2WW Urology
Concurrent haematuria Blood in urine + semen → same-day urology or urgent MSU + urgent referral
PSA elevated Raised PSA or hard/nodular prostate on PR exam → 2WW Urology (prostate cancer)
Weight loss / night sweats Systemic B symptoms alongside haematospermia → urgent cancer pathway
Immunocompromised HIV, immunosuppressants, chemotherapy — higher TB/fungal risk → same-day review
Urethral discharge + fever Systemic sepsis signs: temp >38°C, rigors, rigidity → 999 / same-day (prostatitis / epididymo-orchitis)
Perineal trauma history Recent instrumentation, biopsy, or injury — consider urethral/bladder injury
Travel to endemic areas Sub-Saharan Africa — exclude urogenital schistosomiasis (Schistosoma haematobium)
Haematospermia in men over 40 carries a higher risk of underlying malignancy, particularly prostate cancer — studies suggest up to 3.5% of men presenting to urology with haematospermia have prostate cancer (EAU Guidelines 2023). Concurrent haematuria significantly increases the probability of renal/bladder pathology. Most men under 40 have idiopathic or infective causes. Missing prostate cancer in this context is a significant medicolegal risk and RCGP exam hotspot.
2
Diagnose

History — Characterise the haematospermia

Systematic history determines likely aetiology and risk stratification.

Duration & frequency
First episode vs recurrent (≥3 = investigate); duration >1 month = higher-risk
Colour description
Bright red (fresh bleed) vs brown/dark (older blood); quantity can be misleading
Associated pain
Dysuria, perineal pain, testicular pain → infective or inflammatory cause
Urinary symptoms
LUTS (frequency, poor flow, nocturia) → prostate pathology; haematuria → concurrent UTI or malignancy
Sexual history
STI risk — new partners, unprotected sex, symptoms in partner; GU referral if STI likely
Recent procedures
Prostate biopsy, vasectomy, catheterisation, cystoscopy — iatrogenic cause (self-limiting)
Medical history
Hypertension, bleeding disorders (haemophilia, warfarin/DOAC use), liver disease
Travel history
Sub-Saharan Africa / Middle East → schistosomiasis risk (send urine terminal stream)
History alone can identify over 70% of cases. Post-biopsy haematospermia is the most common cause in referred populations and requires no investigation. Age under 40 + single episode + no systemic symptoms = reassurance and watchful waiting is appropriate (NICE CKS 2023). Age over 40 with recurrence mandates PSA and DRE as a minimum.
3
Diagnose

Classification — Identify likely aetiology

Classify by most likely cause group to direct investigations efficiently.

Iatrogenic (most common)
Post-prostate biopsy, vasectomy, catheterisation → self-limiting within 4–8 weeks; reassure
Infective / inflammatory
Prostatitis, epididymo-orchitis, STIs (chlamydia, gonorrhoea), seminal vesiculitis → treat cause
Idiopathic
No identifiable cause — most common in men <40; resolves spontaneously in 80–90% within 1–2 months
Vascular
Hypertension, AVMs, varicocele → control BP; imaging if persistent
Obstructive
Cysts of seminal vesicles / ejaculatory duct → consider transrectal ultrasound (TRUS)
Systemic
Coagulopathy (anticoagulants, bleeding disorders), liver disease → review medications
Malignant
Prostate cancer, seminal vesicle cancer, testicular cancer (rare) → 2WW Urology
Parasitic
Schistosomiasis (travel) → urine microscopy, specialist referral
Classification drives investigation and management. Idiopathic haematospermia (most common in young men) needs minimal workup. Infective causes need targeted microbiological tests. The key decision is distinguishing between benign/idiopathic (watchful waiting) and high-risk features warranting urology referral (EAU Haematospermia Guidelines 2023).
4
Diagnose

Examination — Targeted genito-urinary assessment

Always examine. Findings significantly alter the management pathway.

Vital signs
BP (elevated BP → vascular cause); temperature (fever → prostatitis/epididymo-orchitis)
Abdomen
Suprapubic tenderness → bladder pathology; renal angle tenderness → upper UTI
External genitalia
Urethral discharge (STI); penile lesions; epididymal/testicular tenderness or swelling
Scrotal exam
Testicular consistency, size, masses → testicular cancer; varicocele (bag of worms)
Digital rectal exam (DRE)
Mandatory in men ≥40: prostate size, consistency, nodularity → hard/irregular = 2WW prostate cancer
Lymph nodes
Inguinal lymphadenopathy → STI, lymphoma
DRE is mandatory in men over 40 presenting with haematospermia. An abnormal prostate (hard, nodular, asymmetric) combined with any PSA rise constitutes an immediate 2WW referral regardless of PSA level (NICE NG12 2023). Not performing DRE is an exam failure criterion in the RCGP SCA. Testicular examination excludes co-existing testicular cancer which, while rare, can present alongside haematospermia.
5
Diagnose

Investigations — Risk-stratified workup

Investigations guided by age and risk. Avoid over-investigating young men with single episodes.

All men ≥40 (or recurrent)
PSA — age-adjusted thresholds (NICE NG12); MSU — exclude UTI/haematuria; FBC, clotting if on anticoagulants
STI screen
Chlamydia / Gonorrhoea NAAT — first-catch urine or urethral swab; refer to GUM if positive or high risk
Haematuria workup
Urine dipstick + MC&S; if positive blood → microscopic haematuria pathway (NICE NG12)
Travel history
Urine for schistosome ova — terminal stream urine x3; eosinophil count
Do NOT routinely order
TRUS, MRI, semen culture — these are urology-led investigations; avoid in primary care
Men <40, single episode
No investigation required if: no red flags, no haematuria, no systemic symptoms — reassure and review at 4 weeks
PSA should be interpreted with age-specific thresholds (NICE NG12 2023): ≥3 ng/mL for 50–69 yrs is the referral threshold. PSA is elevated in prostatitis — consider repeating after treating infection. Over-investigation of young men with single episode haematospermia causes unnecessary anxiety without clinical benefit. TRUS is reserved for urology to exclude seminal vesicle pathology in persistent cases.
6
Refer

Referral Criteria — When to escalate

2WW Urology
Age ≥40 + recurrent haematospermia; abnormal DRE (any age); PSA above age-adjusted threshold; haematuria on dipstick (if not explained by UTI)
Same-day
Fever + perineal pain + systemic sepsis signs (prostatitis/epididymo-orchitis); acute urinary retention
Routine Urology
Age <40, recurrent >3 months despite treatment; suspected seminal vesicle cyst; failed primary care treatment
GUM Clinic
STI confirmed or strongly suspected; contact tracing required; resistant gonorrhoea
Haematology
Coagulopathy identified; anticoagulation review needed
Primary care manage
Age <40, single/isolated episode, no red flags, no haematuria, normal examination → reassure + 4-week safety-net review
NICE NG12 mandates 2WW referral for any man with an unexplained raised PSA or abnormal DRE, regardless of age. Haematospermia alone in a man over 40 is a sufficient indication for urology review even with a normal PSA, as PSA sensitivity for early prostate cancer is only 70–80%. The GP's role is risk stratification and appropriate safety-netting, not definitive investigation of complex haematospermia.
7
Treat

Treatment — Cause-directed management

Treatment is cause-specific. Most idiopathic cases require reassurance only.

Idiopathic / Age <40
Reassurance 1st line
Self-limiting in 80–90%. No pharmacological treatment needed. Partner reassurance — not contagious, not sexually transmitted.
Bacterial prostatitis
Ciprofloxacin Antibiotic
500 mg BD × 28 days (acute); or Trimethoprim 200 mg BD × 28 days if quinolone-resistant. Review at 4 weeks.
Chlamydia confirmed
Doxycycline Antibiotic
100 mg BD × 7 days (BASHH 2023 guideline). Contact trace. Partner treatment.
Hypertension-related
Optimise BP control
Target BP <140/90 mmHg. Review current antihypertensives. May resolve with adequate BP control.
Anticoagulant-related
Review anticoagulation
Check INR if warfarin (supratherapeutic?). DOAC: review indication vs bleeding risk. Do not stop without specialist advice.
If no improvement at 4 wksRepeat PSA if not done; re-examine; consider urology referral
Persistent >3 monthsUrology referral for TRUS ± MRI prostate regardless of age
Reassurance is the most powerful intervention for idiopathic haematospermia — anxiety about the symptom often exceeds clinical risk. Prolonged antibiotic courses (4 weeks) are required for prostatitis due to poor antibiotic penetration into prostatic tissue (NICE CKS Prostatitis 2023). Quinolones achieve the best prostatic tissue concentrations. Do not use short courses — relapse is common.
8
Lifestyle

Non-Pharmacological — Patient education and self-care

Reassurance first Most men are terrified. Explain >90% are benign. This is often the most therapeutic intervention.
Partner communication Not sexually transmitted. Partner does not need investigation or treatment (unless STI confirmed).
Blood pressure monitoring Home BP monitoring if hypertensive. Target <135/85 home BP. Sustained control may resolve vascular haematospermia.
STI prevention Condom use if new partners. Signpost to sexual health services / NHS online STI testing.
Alcohol moderation Limit to ≤14 units/week. Alcohol worsens coagulopathy and liver-related bleeding tendency.
PSA awareness If age ≥50, discuss prostate cancer risk factors and NHS prostate cancer awareness (no screening programme yet in UK).
Anxiety about haematospermia is often disproportionate to clinical risk. Studies show men often delay presentation for months, believing it indicates serious disease. Clear, confident reassurance reduces re-attendance. Blood pressure control has been shown to reduce recurrence in hypertensive patients. STI prevention is primary prevention of the infective subgroup — the commonest treatable cause in men under 40.
9
Safety

Follow-Up & Safety-Netting

4 weeks
Review: has it resolved? Check infection treatment response; repeat MSU if haematuria; repeat PSA if elevated and prostatitis treated
3 months
If persistent despite treatment → urology referral (routine or urgent depending on new findings)
Annual (if risk factors)
Men ≥50 with hypertension or family history of prostate cancer — prostate health discussion, PSA if requested (informed consent)
999 now
Fever + rigors + perineal pain + unable to pass urine → septic prostatitis or urinary retention
Same-day GP
New haematuria; acute testicular/scrotal pain; worsening systemic symptoms; unable to tolerate antibiotics
Re-refer if
PSA rises on repeat; DRE becomes abnormal; haematuria develops; weight loss or night sweats appear
The 4-week review serves two functions: confirming resolution (the majority) and catching the minority where underlying pathology is emerging. A repeat PSA after antibiotic treatment for prostatitis removes the confounding effect of inflammation on PSA (prostatitis can raise PSA 10-fold). Safety-netting for urinary retention is critical — acute retention secondary to prostatitis is a urological emergency.
Educational use only. Pathway based on: NICE NG12 (Suspected cancer referral 2023), NICE CKS Haematospermia (2023), EAU Guidelines on Haematospermia (2023), BASHH STI Guidelines (2023), NICE CKS Prostatitis (2023). Always adapt to individual patient context and local guidelines. Not a substitute for clinical judgement.